- RecruitingPHASE2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
This study looks at new drug combinations before and after surgery for early-stage lung cancer. It aims to see if these treatments are safe and work well to help people with non-small cell lung cancer.
For: Non-small Cell Lung CancerUnited States · Belgium · Canada - Active not recruitingPHASE2
Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
This study is looking at a new combination of medicines - AZD0171, durvalumab, and standard chemotherapy - for people with advanced pancreatic cancer. It aims to see how safe and effective this new treatment is.
For: Locally Advanced or Metastatic Solid TumoursUnited States · Canada · South Korea